Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

OTLK vs ACDC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

OTLK Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 7–3 Matrix Metrics)

OTLK Overall Winner 6-Pillar Tally: OTLK 3 – 3 ACDC Matrix Metrics: OTLK 7 – 3 ACDC

As of Nov 16, 2026, Outlook Therapeutics, Inc. (OTLK) is the stronger overall head-to-head candidate over ProFrac Holding Corp. (ACDC) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). OTLK carries a Unified Composite Score of 48.6/100 (HOLD) at $0.40 (2.9x Forward P/E, 4781.8% operating margin), whereas ACDC carries 51.8/100 (HOLD) at $3.10 (16.2x Forward P/E, -8.1% operating margin).

  • Composite vs. Pillar Nuance: While ACDC currently prints a higher short-term Unified Composite Score (51.8/100 HOLD vs. OTLK 48.6/100 HOLD), OTLK captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (4781.8% vs. -8.1% operating margin) and revenue trajectory (-99.4% vs. +26.8% YoY).
  • Technical & Structure Timing Caution: OTLK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 31.2); meanwhile ACDC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About OTLK vs ACDC
OTLK NASDAQ Head-to-Head Winner
Outlook Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.40
-4.04% 1D
Market Cap $107.1M
TTM Revenue N/A
Forward P/E 2.9x
Beta / 30D Vol 1.47β · 79% Vol
Unified Composite Score
48.6 / 100 HOLD
Tech 33.0 Fund 48.0 Flow 71.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -15.5%), weak momentum, RSI 31
RSI-14: 31.2 · SMA20: $0.48 · SMA50: $0.56
ACDC NASDAQ
ProFrac Holding Corp. Class A Common Stock
Oil & Gas Field Services, Nec
$3.10
-1.75% 1D
Market Cap $581.0M
TTM Revenue $1.90B
Forward P/E 16.2x
Beta / 30D Vol 1.48β · 149% Vol
Unified Composite Score
51.8 / 100 HOLD
Tech 65.0 Fund 62.0 Flow 57.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.3%), weak momentum, RSI 36
RSI-14: 36.3 · SMA20: $3.89 · SMA50: $4.37

6-Pillar Scorecard Institutional Category Breakdown (OTLK 3 – 3 ACDC)

Columns: Metric · OTLK · ACDC
1. Valuation Multiples OTLK
Forward P/E 2.9x 16.2x
Trailing P/E 2.9x 16.2x
PEG Ratio N/M N/M
EV / Revenue N/M 0.9x
2. Growth & Scale ACDC
Revenue Growth (YoY) -99.4% +26.8%
Earnings Growth (YoY) +0.0% -99.1%
TTM Revenue (USD) N/A $1.90B
Market Cap $107.1M $581.0M
3. Profitability & Quality OTLK
Gross Margin N/A 21.8%
Operating Margin 4781.8% -8.1%
Net Profit Margin 0.0% -20.4%
Return on Equity (ROE) -3.6% -42.9%
4. Balance Sheet & Cash Flow ACDC
Cash Generation (TTM) -$56M -$16M
Cash Flow Margin N/A -0.8%
Net Cash / Leverage $7.2M Net Debt $1.11B Net Debt (2.28x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning OTLK
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile 181.3% (55th %ile) 95.6% (7th %ile)
Put/Call OI Skew 0.26x (Call-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat ACDC
OpEx & R&D Intensity N/A 29.9% of Rev ($567M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Oil & Gas Equipment & Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: OTLK (7) vs ACDC (3)
Institutional Metric OTLK ACDC Criterion Row Edge
Market Capitalization
Scale
$107.1M $581.0M Larger Scale ACDC
Trailing P/E Ratio
Valuation
2.9x 16.2x Lower Multiple OTLK
Forward P/E Ratio
Valuation
2.9x 16.2x Lower Multiple OTLK
Revenue Growth (YoY)
Growth
-99.4% +26.8% Higher Growth ACDC
Operating Margin (TTM)
Profitability
4781.8% -8.1% Higher Margin OTLK
Net Profit Margin
Profitability
0.0% -20.4% Higher Margin OTLK
Return on Equity (ROE)
Capital Efficiency
-3.6% -42.9% Higher ROE OTLK
52-Week Range Position
Momentum
10% ($0–$3) 8% ($3–$8) Stronger Trend OTLK
Beta / 30D Volatility
Risk Regime
1.47β · 79% Vol 1.48β · 149% Vol Lower Realized Risk OTLK
Unified Institutional Score
Composite Signal
48.6 / 100 (HOLD) 51.8 / 100 (HOLD) Higher Composite ACDC
Trailing 12M Revenue (USD)
Operating Scale
N/A $1.90B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 21.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 0.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$56M ($7.2M Net Debt) -$16M ($1.11B Net Debt (2.28x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon OTLK +4.38 pp
OTLK: -18.82% · ACDC: -23.2%
3M Horizon ACDC +4.2 pp
OTLK: -43.39% · ACDC: -39.19%
6M Horizon OTLK +133.28 pp
OTLK: +72.91% · ACDC: -60.37%
1Y Horizon ACDC +56.69 pp
OTLK: -73.04% · ACDC: -16.35%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period OTLK Revenue ACDC Revenue OTLK Op. Margin ACDC Op. Margin Margin Leader
FY2018 $0M N/A -960.1% N/A OTLK
FY2019 $10M N/A -445.6% N/A OTLK
FY2020 N/A $550M N/A -17.3% ACDC
FY2021 N/A $770M N/A -2.3% ACDC
FY2022 N/A $2.43B N/A 17.0% ACDC
FY2023 N/A $2.63B N/A 6.3% ACDC
FY2024 N/A $2.19B N/A -2.8% ACDC
FY2025 $0M $1.94B -4744.3% -11.6% ACDC

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
OTLK BREAKDOWN
103d in phase · OBV NEUTRAL
Current IV 181.3%
IV Percentile 55th %ile
Put/Call OI Skew 0.26x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact OTLK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ACDC BREAKDOWN
125d in phase · OBV DISTRIBUTION
Current IV 95.6%
IV Percentile 7th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact ACDC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
OTLK Moat Profile High-Margin Pricing Power Moat
Biotechnology Operator
Competes within the Biotechnology value chain with $107.1M market capitalization and 4781.8% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ACDC Moat Profile Cyclical / Execution-Driven Positioning
Oil & Gas Equipment & Services Operator
Competes within the Oil & Gas Equipment & Services value chain with $581.0M market capitalization and -8.1% operating margin.
OpEx & R&D Reinvestment 29.9% of Rev ($567M)
90D Engineering Disclosures 0 Published

Investor FAQ OTLK vs ACDC Key Questions & Quantitative Answers

As of Nov 16, 2026, Outlook Therapeutics, Inc. (OTLK) is the stronger overall head-to-head candidate over ProFrac Holding Corp. (ACDC) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). OTLK carries a Unified Composite Score of 48.6/100 (HOLD) at $0.40 (2.9x Forward P/E, 4781.8% operating margin), whereas ACDC carries 51.8/100 (HOLD) at $3.10 (16.2x Forward P/E, -8.1% operating margin). Composite vs. Pillar Nuance: While ACDC currently prints a higher short-term Unified Composite Score (51.8/100 HOLD vs. OTLK 48.6/100 HOLD), OTLK captures the overall institutional head-to-head verdict (7–3 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (4781.8% vs. -8.1% operating margin) and revenue trajectory (-99.4% vs. +26.8% YoY). Technical & Structure Timing Caution: OTLK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 31.2); meanwhile ACDC is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 36.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ACDC leads the Growth & Scale pillar: OTLK posts -99.4% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 4781.8% operating margin), compared with ACDC at +26.8% YoY revenue growth and -99.1% YoY earnings growth on $1.90B TTM revenue (21.8% gross margin, -8.1% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), OTLK cumulative revenue shifted N/A while ACDC shifted +252.7%. In operating R&D and SG&A reinvestment, OTLK deploys N/A (0 90-day corporate R&D disclosures) versus 29.9% of Rev ($567M) (0 disclosures) for ACDC.

OTLK screens cheaper on headline valuation multiples. OTLK trades at 2.9x Forward P/E, 2.9x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas ACDC trades at 16.2x Forward P/E, 16.2x Trailing P/E, N/M PEG, and 0.9x EV/Revenue (-0.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against OTLK (-3.6% ROE) versus ACDC (-42.9% ROE) capital efficiency.

In options market volatility and institutional positioning, OTLK carries 181.3% implied volatility (55th %ile, Balanced (25th–60th %ile)), a 0.26x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (1.47β · 79% Vol realized risk). By comparison, ACDC carries 95.6% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.48β · 149% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.